Substrate
Topic

genomic testing

2 stories related to this topic, newest first.

Tumor Mutations Often Unidentified, Limiting Use of Advanced Targeted TherapiesSubstrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)
science28 days ago

Tumor Mutations Often Unidentified, Limiting Use of Advanced Targeted Therapies

Many advanced targeted therapies remain unused because mutations in tumors are not identified through testing. According to STAT News, this gap affects patient treatment options in oncology. The issue highlights challenges in precision medicine implementation.

ST
1 source
Many Cancer Patients Not Receiving Genomic Testing Despite Treatment AdvancesSubstrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)
science28 days ago

Many Cancer Patients Not Receiving Genomic Testing Despite Treatment Advances

A report indicates that a significant number of cancer patients are not undergoing genomic testing, which can identify targeted therapies. This testing analyzes tumor DNA to match treatments to specific genetic mutations. The gap persists even as precision medicine options expand…

ST
1 source